What did Pfizer know about the adulteration, and what did FDA know? With a novel gene therapy drug, such as Pfizer's COVID-19 vaccine, the public must be confident that manufacturing, batch analyses, and drug stability - indeed all quality control issues - are done appropriately.
What I found is that the FDA produced only two meaningless documents related to quality among the over two thousand Pfizer documents it has released to date as a result of Aaron Siri's lawsuit to release the Pfizer documents.
An informed source told DailyClout: "In September's production, [the FDA] withheld 834 records in full pursuant to (4) - trade secrets." The wording implies that what was withheld is related to manufacture or formulation - i.e., 'Module 3' Quality documentation.
In order for a drug, such as Pfizer's mRNA COVID-19 vaccine, to be considered by the FDA for emergency use authorization or approval, the pharmaceutical company must submit extensive documentation, defined by the FDA, for the FDA's review.
How can the FDA withhold that documentation when the Court has ordered Pfizer to release its clinical trial documents to the public?
The(4) exemption "Of FOIA permits agencies, as a matter of discretion, to withhold trade secrets and commercial or financial information obtained from a person which is privileged or confidential." Is this "Trade secrets" carve-out being invoked now that such appalling evidence has surfaced about the drug's contamination?
"The FDA's"Comprehensive Table of Contents Headings and Hierarchy" shows us exactly what the FDA is withholding from public analysis by hiding Module 3 Quality documentation.
No comments:
Post a Comment